Jim Tananbaum

Seranova Bio LLC, founded in 2020, is a company based in New Haven, CT that is focused on establishing a new paradigm for therapeutic target discovery. The company's Rapid Extracellular Antigen Profiling (REAP) platform combines high-quality, comprehensive protein sampling with next-generation DNA sequencing to profile patients' autoantibodies with higher throughput and fidelity than existing technologies. Seranova Bio's technological breakthrough reveals, in much greater depth, the underlying humoral response to disease and provides critical insights to drug developers. The company aims to collaborate with pharmaceutical partners to discover novel therapeutic targets and develop new treatments for autoimmune disease, neurodegeneration, and cancer.